Genestack
Private Company
Total funding raised: $7.5M
Overview
Genestack is a private, revenue-generating bioinformatics platform company addressing the critical data integration challenges in life science R&D. Its primary offering, the Open Data Manager (ODM), creates a centralized, FAIR-compliant data catalog that enables AI-driven research by harmonizing diverse data types like genomics, proteomics, and radiomics. The company serves a blue-chip client base including top-10 biopharma firms like AstraZeneca, leading agriscience companies like Bayer and Bejo, and prestigious academic institutions like the Wellcome Sanger Institute. Founded by a former EBI group leader and established as a joint venture with software tool giant JetBrains, Genestack is positioned as a key enabler for accelerating drug discovery, precision medicine, and agricultural innovation.
Technology Platform
Open Data Manager (ODM): A FAIR-compliant, AI-ready data catalog and harmonization platform for multi-omics, imaging, and other biological data. It features AI-powered curation, integrative search, and API-driven integration without requiring data migration.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Genestack competes in a crowded market with established bioinformatics platforms (e.g., DNAnexus, Partek), cloud-native solutions from AWS/Google/Microsoft, and a fragmented landscape of open-source tools. Its differentiation lies in its specific focus on FAIR data harmonization for AI, a 'no migration' architecture, and strong validation from top-tier life science enterprises.